Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ST Pharm financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩94.7 K
2024-10-29
Market Capitalization
₩1.9 T
2024-10-29
Revenue
₩331.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 97.7B | 93.3B | 124.1B | 165.6B | 249.3B | 285.0B | 273.8B | 331.7B |
| Cost of goods sold | 62.2B | 56.4B | 49.5B | 57.6B | 104.1B | 153.3B | 155.3B | 169.3B |
| Gross profit | 35.6B | 37.3B | 78.6B | 108.1B | 146.1B | 132.3B | 118.9B | 162.8B |
| Gross profit margin, % | 40.0% | 63.4% | 65.3% | 58.6% | 46.4% | 43.4% | 49.1% | |
| Operating expense total | 41.9B | 52.4B | 80.4B | 88.0B | 109.7B | 75.2B | 65.2B | 77.5B |
| Depreciation and amortization | 9.2B | 11.2B | 13.1B | 14.4B | 17.6B | 23.0B | 25.5B | 29.8B |
| EBITDA | (6.3B) | (15.1B) | (1.7B) | 20.1B | 36.3B | 57.1B | 53.5B | 85.2B |
| EBITDA margin, % | -16.2% | -1.4% | 12.1% | 14.6% | 20.0% | 19.5% | 25.7% | |
| EBIT | (15.7B) | (27.1B) | (14.9B) | 5.6B | 18.5B | 33.6B | 27.5B | 54.6B |
| EBIT margin, % | -29.0% | -12.0% | 3.4% | 7.4% | 11.8% | 10.1% | 16.5% | |
| Interest income | 1.5B | 1.3B | 618.0M | 939.4M | 1.2B | 2.4B | 4.6B | 3.5B |
| Interest expense | 78.9M | 644.6M | 5.2B | 2.9B | 6.1B | 7.7B | 4.0B | |
| Pre tax profit | (13.4B) | (25.0B) | (16.8B) | 1.3B | 19.2B | 23.4B | 42.7B | 58.7B |
| Income tax expense | (4.1B) | (6.4B) | (3.7B) | (2.1B) | 1.7B | 5.8B | 10.3B | 4.2B |
| Net Income | (9.3B) | (18.5B) | (13.2B) | 3.4B | 17.5B | 17.5B | 32.5B | 54.6B |